Literature DB >> 34437837

Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis.

Chun Gong1, Joanna A Krupka2, Jie Gao1, Nicholas F Grigoropoulos3, George Giotopoulos1, Ryan Asby1, Michael Screen4, Zelvera Usheva1, Francesco Cucco5, Sharon Barrans6, Daniel Painter7, Nurmahirah Binte Mohammed Zaini3, Björn Haupl8, Susanne Bornelöv9, Igor Ruiz De Los Mozos10, Wei Meng11, Peixun Zhou12, Alex E Blain13, Sorcha Forde5, Jamie Matthews5, Michelle Guet Khim Tan14, G A Amos Burke15, Siu Kwan Sze11, Philip Beer16, Cathy Burton6, Peter Campbell16, Vikki Rand12, Suzanne D Turner17, Jernej Ule10, Eve Roman7, Reuben Tooze18, Thomas Oellerich8, Brian J Huntly1, Martin Turner4, Ming-Qing Du5, Shamith A Samarajiwa19, Daniel J Hodson20.   

Abstract

DDX3X is a ubiquitously expressed RNA helicase involved in multiple stages of RNA biogenesis. DDX3X is frequently mutated in Burkitt lymphoma, but the functional basis for this is unknown. Here, we show that loss-of-function DDX3X mutations are also enriched in MYC-translocated diffuse large B cell lymphoma and reveal functional cooperation between mutant DDX3X and MYC. DDX3X promotes the translation of mRNA encoding components of the core translational machinery, thereby driving global protein synthesis. Loss-of-function DDX3X mutations moderate MYC-driven global protein synthesis, thereby buffering MYC-induced proteotoxic stress during early lymphomagenesis. Established lymphoma cells restore full protein synthetic capacity by aberrant expression of DDX3Y, a Y chromosome homolog, the expression of which is normally restricted to the testis. These findings show that DDX3X loss of function can buffer MYC-driven proteotoxic stress and highlight the capacity of male B cell lymphomas to then compensate for this loss by ectopic DDX3Y expression.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Burkitt lymphoma; DDX3X; MYC; RNA helicase; germinal center; proteotoxic stress; translation

Mesh:

Substances:

Year:  2021        PMID: 34437837     DOI: 10.1016/j.molcel.2021.07.041

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   19.328


  7 in total

1.  Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.

Authors:  Birgit Burkhardt; Ulf Michgehl; Jonas Rohde; Tabea Erdmann; Philipp Berning; Katrin Reutter; Marius Rohde; Arndt Borkhardt; Thomas Burmeister; Sandeep Dave; Alexandar Tzankov; Martin Dugas; Sarah Sandmann; Falko Fend; Jasmin Finger; Stephanie Mueller; Nicola Gökbuget; Torsten Haferlach; Wolfgang Kern; Wolfgang Hartmann; Wolfram Klapper; Ilske Oschlies; Julia Richter; Udo Kontny; Mathias Lutz; Britta Maecker-Kolhoff; German Ott; Andreas Rosenwald; Reiner Siebert; Arend von Stackelberg; Brigitte Strahm; Wilhelm Woessmann; Martin Zimmermann; Myroslav Zapukhlyak; Michael Grau; Georg Lenz
Journal:  Nat Commun       Date:  2022-07-06       Impact factor: 17.694

2.  DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.

Authors:  Atish Kizhakeyil; Nurmahirah Binte Mohammed Zaini; Zhi Sheng Poh; Nicholas Francis Grigoropoulos; Navin Kumar Verma; Brandon Han Siang Wong; Xinpeng Loh; Aik Seng Ng; Zun Siong Low; Praseetha Prasannan; Chun Gong; Michelle Guet Khim Tan; Chandramouli Nagarajan; Dachuan Huang; Pang Wan Lu; Jing Quan Lim; Sharon Barrans; Choon Kiat Ong; Soon Thye Lim; Wee Joo Chng; George Follows; Daniel J Hodson; Ming Qing Du; Yeow Tee Goh; Suat Hoon Tan
Journal:  Mol Cancer       Date:  2021-10-16       Impact factor: 27.401

3.  DDX3X and DDX3Y are redundant in protein synthesis.

Authors:  Srivats Venkataramanan; Margaret Gadek; Lorenzo Calviello; Kevin Wilkins; Stephen N Floor
Journal:  RNA       Date:  2021-09-17       Impact factor: 4.942

4.  Shared and distinct genetic features in human and canine B-cell lymphomas.

Authors:  Krysta Mila Coyle; Tiana Hillman; Matthew Cheung; Bruno M Grande; Kevin R Bushell; Sarah E Arthur; Miguel Alcaide; Nicole Thomas; Kostiantyn Dreval; Stephanie Wong; Krishanna Campbell; Ryan D Morin
Journal:  Blood Adv       Date:  2022-06-14

5.  DDX55 promotes hepatocellular carcinoma progression by interacting with BRD4 and participating in exosome-mediated cell-cell communication.

Authors:  Bin Yu; Shujun Zhou; Dakun Long; Yuxiang Ning; Hanlin Yao; Encheng Zhou; Yanfeng Wang
Journal:  Cancer Sci       Date:  2022-06-10       Impact factor: 6.518

6.  Proteotoxic stress-induced apoptosis in cancer cells: understanding the susceptibility and enhancing the potency.

Authors:  Luca Iuliano; Emiliano Dalla; Raffaella Picco; Showmeya Mallavarapu; Martina Minisini; Eleonora Malavasi; Claudio Brancolini
Journal:  Cell Death Discov       Date:  2022-10-04

7.  Multifunctional RNA-binding proteins influence mRNA abundance and translational efficiency of distinct sets of target genes.

Authors:  Valentin Schneider-Lunitz; Jorge Ruiz-Orera; Norbert Hubner; Sebastiaan van Heesch
Journal:  PLoS Comput Biol       Date:  2021-12-08       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.